FIELD: medical engineering. SUBSTANCE: device has means for magnetizing arranged relative to detector means in a position that magnetic field produced by the means for magnetizing is weakened at the magnetized place by at least factor 10 or preferentially by factor 1000 or more at the place the sample is disposed for measuring period. A switch usable for turning off the magnetic field produced by means for magnetizing at the place the sample is present at given time being in particular measuring phase of detector means. EFFECT: low cost and standardized magnetorelaxation analyte detection in vitro and in vivo. 32 cl, 5 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETECTING ANALYTE FROM PARTICLE SOLUTION AND DEVICE FOR IMPLEMENTING IT | 2011 |
|
RU2528885C2 |
SUBSTANCES AND METHOD FOR DETECTING ANALYTES BY MEASURING RESIDUAL MAGNETIC INDUCTION | 1996 |
|
RU2175136C2 |
ANTIBODIES USEFUL IN DIAGNOSING CANCER | 2018 |
|
RU2815883C1 |
THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER | 2014 |
|
RU2678700C2 |
PREDICTION OF IMMUNOGENICITY OF T-CELL EPITOPES | 2014 |
|
RU2724370C2 |
COMBINED THERAPY WITH CLAUDINE 18.2 ANTIBODIES FOR CANCER TREATMENT | 2014 |
|
RU2699549C2 |
ANTIBODIES AGAINST CLAUDIN 18.2 FOR CANCER DIAGNOSIS | 2013 |
|
RU2661772C2 |
DEVICE AND PROCESS TO CONDUCT IMMUNOFLUORESCENT ANALYSES | 1998 |
|
RU2194972C2 |
INDIVIDUALIZED ANTI-TUMOR VACCINES | 2012 |
|
RU2779946C2 |
MEANS AND METHODS FOR DIAGNOSING AND TREATING MULTIPLE SCLEROSIS | 2012 |
|
RU2601298C2 |
Authors
Dates
2003-11-27—Published
1997-03-26—Filed